Teleflex Incorporated $TFX Stock Holdings Decreased by SG Americas Securities LLC

SG Americas Securities LLC lessened its stake in Teleflex Incorporated (NYSE:TFX) by 50.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,867 shares of the medical technology company’s stock after selling 4,994 shares during the quarter. SG Americas Securities LLC’s holdings in Teleflex were worth $596,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of TFX. Russell Investments Group Ltd. lifted its holdings in Teleflex by 23.6% during the 2nd quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company’s stock worth $9,870,000 after buying an additional 15,935 shares during the last quarter. Speece Thorson Capital Group Inc. lifted its stake in Teleflex by 2.4% during the second quarter. Speece Thorson Capital Group Inc. now owns 89,843 shares of the medical technology company’s stock worth $10,634,000 after purchasing an additional 2,096 shares during the last quarter. Creative Planning boosted its holdings in Teleflex by 76.5% in the second quarter. Creative Planning now owns 10,338 shares of the medical technology company’s stock worth $1,224,000 after purchasing an additional 4,480 shares during the period. CWM LLC increased its stake in Teleflex by 160.8% during the second quarter. CWM LLC now owns 11,904 shares of the medical technology company’s stock valued at $1,409,000 after purchasing an additional 7,340 shares during the last quarter. Finally, Teacher Retirement System of Texas raised its holdings in shares of Teleflex by 31.5% during the second quarter. Teacher Retirement System of Texas now owns 11,819 shares of the medical technology company’s stock worth $1,399,000 after purchasing an additional 2,831 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Up 2.1%

Teleflex stock opened at $105.09 on Friday. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $185.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53. The stock has a market capitalization of $4.64 billion, a PE ratio of -14.30, a price-to-earnings-growth ratio of 1.34 and a beta of 0.93. The firm has a 50 day simple moving average of $116.34 and a 200-day simple moving average of $120.11.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.29. The firm had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The firm’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.36 annualized dividend and a yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is currently -18.50%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on TFX. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Wells Fargo & Company lifted their target price on Teleflex from $114.00 to $139.00 and gave the company an “equal weight” rating in a research note on Wednesday, December 10th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Tuesday, December 9th. Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Finally, Zacks Research downgraded Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. One equities research analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Teleflex currently has a consensus rating of “Reduce” and a consensus target price of $142.43.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.